Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24851
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | de Waard, E. A. C. | - |
dc.contributor.author | Driessen, J. H. M. | - |
dc.contributor.author | de Jong, J. J. A. | - |
dc.contributor.author | van Geel, T. A. C. M. | - |
dc.contributor.author | Henry, R. M. A. | - |
dc.contributor.author | van Onzenoort, H. A. W. | - |
dc.contributor.author | Schram, M. T. | - |
dc.contributor.author | Dagnelie, P. C. | - |
dc.contributor.author | VAN DER KALLEN, Carla | - |
dc.contributor.author | Sep, S. J. S. | - |
dc.contributor.author | Stehouwer, C. D. A. | - |
dc.contributor.author | Schaper, N. C. | - |
dc.contributor.author | Koster, Annemarie | - |
dc.contributor.author | Savelberg, H. H. C. M. | - |
dc.contributor.author | Neef, C. | - |
dc.contributor.author | GEUSENS, Piet | - |
dc.contributor.author | de Vries, F. | - |
dc.contributor.author | VAN DEN BERGH, Joop | - |
dc.date.accessioned | 2017-09-25T13:07:35Z | - |
dc.date.available | 2017-09-25T13:07:35Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | BONE, 101, p. 156-161 | - |
dc.identifier.issn | 8756-3282 | - |
dc.identifier.uri | http://hdl.handle.net/1942/24851 | - |
dc.description.abstract | Type 2 diabetes mellitus (T2DM) has been associated with an increased risk of fractures, despite normal to increased bone mineral density (BMD). Insulin use is one of the factors linked to this increased fracture risk. However, direct negative effects of insulin on bone quality are not expected since insulin is thought to be anabolic to bone. In this cross-sectional study the association between insulin use and volumetric BMD (vBMD), bone micro architecture and bone strength of the distal radius, as measured with HR-pQCT, was examined. Data from 50 participants with T2DM of The Maastricht Study (mean age 62 +/- 7.5 years, 44% women) was used. Participants were classified as insulin user (n = 13) or non-insulin user (n = 37) based on prescription data. Linear regression analysis was used to estimate the association between current insulin use and HR-pQCF derived parameters. After adjustment for age, sex, body mass index, glycated hemoglobin Al c and T2DM duration, insulin use was associated with lower total vBMD (standardized beta (beta):-0.56 (95% CI: 0.89 to 0.24)), trabecular vBMD ((3:-0.58 (95% CI: 0.87 to 0.30)), trabecular thickness (beta: 0.55 (95% CI: 0.87 to 0.23)), cortical thickness (beta: 0.41 (95% CI: 0.74 to 0.08)), log cortical pore volume (beta: 0.43 (95% Cf: 0.73 to 0.13)), bone stiffness (beta:-0.39 (95% CI: 0.62 to 0.17)) and failure load (beta:-0.39 (95% CI: 0.60 to 0.17)) when compared to the non-insulin users. Insulin use was not associated with cortical vBMD, trabecular number, trabecular separation, cortical porosity and cortical pore diameter. This study indicates thatinsulin use is negatively associated with bone density, bone micro-architectural and bone strength parameters: These findings may partly explain the previously observed increased fracture risk in insulin users, although there may be residual confounding by other factors related to disease severity in insulin users. (C) 2017 Elsevier Inc. All rights reserved. | - |
dc.description.sponsorship | This study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands), School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands), School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.rights | © 2017 Elsevier Inc. All rights reserved. | - |
dc.subject.other | Insulin use; Type 2 diabetes mellitus; High-resolution peripheral quantitative computed tomography (HR-pQCT); Volumetric bone mineral density; Bone micro-architecture; Bone strength | - |
dc.subject.other | insulin use; type 2 diabetes mellitus; high-resolution peripheral quantitative computed tomography (HR-pQCT); volumetric bone mineral density; bone micro-architecture; bone strength | - |
dc.title | The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht study | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 161 | - |
dc.identifier.spage | 156 | - |
dc.identifier.volume | 101 | - |
local.format.pages | 6 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [de Waard, E. A. C.; de Jong, J. J. A.] Maastricht Univ, Dept Internal Med, Maastricht, Netherlands. [de Waard, E. A. C.; Driessen, J. H. M.; de Jong, J. J. A.; Savelberg, H. H. C. M.; van den Bergh, J. P. W.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands. [Driessen, J. H. M.; de Vries, F.] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Driessen, J. H. M.; van Geel, T. A. C. M.; Dagnelie, P. C.; Koster, A.; Neef, C.; Geusens, P. P. M. M.; de Vries, F.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands. [Driessen, J. H. M.; van Onzenoort, H. A. W.; Neef, C.; de Vries, F.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands. [van Geel, T. A. C. M.] Maastricht Univ, Dept Family Med, Maastricht, Netherlands. [Henry, R. M. A.; Schram, M. T.; van der Kallen, C. J.; Sep, S. J. S.; Stehouwer, C. D. A.; Schaper, N. C.; Geusens, P. P. M. M.; van den Bergh, J. P. W.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands. [Henry, R. M. A.; Schram, M. T.; Dagnelie, P. C.; van der Kallen, C. J.; Sep, S. J. S.; Stehouwer, C. D. A.; Schaper, N. C.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands. [Schram, M. T.] Maastricht Univ, Med Ctr, Heart & Vasc Ctr, Maastricht, Netherlands. [van Onzenoort, H. A. W.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands. [Dagnelie, P. C.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands. [Koster, A.] Maastricht Univ, Dept Social Med, Maastricht, Netherlands. [Savelberg, H. H. C. M.] Maastricht Univ, Dept Human Movement Sci, Maastricht, Netherlands. [Geusens, P. P. M. M.] Univ Hasselt, Biomed Res Inst, Hasselt, Belgium. [de Vries, F.] Southampton Gen Hosp, MRC Epidemiol Lifecourse Unit, Southampton, Hants, England. [van den Bergh, J. P. W.] VieCuri Med Ctr, Dept Internal Med, Subdiv Endocrinol, Venlo, Netherlands. | - |
local.publisher.place | NEW YORK | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1016/j.bone.2017.05.004 | - |
dc.identifier.isi | 000404319300019 | - |
item.fulltext | With Fulltext | - |
item.accessRights | Restricted Access | - |
item.validation | ecoom 2018 | - |
item.contributor | de Waard, E. A. C. | - |
item.contributor | Driessen, J. H. M. | - |
item.contributor | de Jong, J. J. A. | - |
item.contributor | van Geel, T. A. C. M. | - |
item.contributor | Henry, R. M. A. | - |
item.contributor | van Onzenoort, H. A. W. | - |
item.contributor | Schram, M. T. | - |
item.contributor | Dagnelie, P. C. | - |
item.contributor | VAN DER KALLEN, Carla | - |
item.contributor | Sep, S. J. S. | - |
item.contributor | Stehouwer, C. D. A. | - |
item.contributor | Schaper, N. C. | - |
item.contributor | Koster, Annemarie | - |
item.contributor | Savelberg, H. H. C. M. | - |
item.contributor | Neef, C. | - |
item.contributor | GEUSENS, Piet | - |
item.contributor | de Vries, F. | - |
item.contributor | VAN DEN BERGH, Joop | - |
item.fullcitation | de Waard, E. A. C.; Driessen, J. H. M.; de Jong, J. J. A.; van Geel, T. A. C. M.; Henry, R. M. A.; van Onzenoort, H. A. W.; Schram, M. T.; Dagnelie, P. C.; VAN DER KALLEN, Carla; Sep, S. J. S.; Stehouwer, C. D. A.; Schaper, N. C.; Koster, Annemarie; Savelberg, H. H. C. M.; Neef, C.; GEUSENS, Piet; de Vries, F. & VAN DEN BERGH, Joop (2017) The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht study. In: BONE, 101, p. 156-161. | - |
crisitem.journal.issn | 8756-3282 | - |
crisitem.journal.eissn | 1873-2763 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
de waard 1.pdf Restricted Access | Published version | 275.5 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
6
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
12
checked on May 8, 2024
Page view(s)
74
checked on Sep 6, 2022
Download(s)
62
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.